VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription

Epigenetics

Volumn 10, Issue 1, 2015, Pages 40-49

  Singh, Prashant K ^a   Long, Mark D ^a   Battaglia, Sebastiano ^a   Hu, Qiang ^a   Liu, Song ^a   Sucheston Campbell, Lara E ^a   Campbell, Moray J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Epigenetic regulation; MicroRNA; Prostate cancer; VDR; Vitamin D

Indexed keywords

CALCITRIOL; MESSENGER RNA; MICRORNA; MICRORNA 138; MICRORNA 140 5P; MICRORNA 30E; MICRORNA 92A; MICRORNA 98; TRANSCRIPTOME; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROSTATE CANCER; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TRANSLATION REGULATION; ANTIBODY SPECIFICITY; CLASSIFICATION; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MALE; METABOLISM; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; EPIGENESIS, GENETIC; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; ORGAN SPECIFICITY; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RNA, MESSENGER;

EID: 84924354941     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/15592294.2014.989088     Document Type: Article

References (79)

1. Thorne JL, Campbell MJ, Turner BM. Transcription factors, chromatin and cancer. Int J Biochem Cell Biol 2009; 41:164-75; PMID:18804550; http://dx.doi.org/10.1016/j.biocel.2008.08.029
2. Long MD, Thorne JL, Russell J, Battaglia S, Singh PK, Sucheston-Campbell LE, Campbell MJ. Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer. Carcinogenesis 2014; 35:262-71; PMID:24104552; http://dx.doi.org/10.1093/carcin/bgt334
3. Battaglia S, Maguire O, Thorne JL, Hornung LB, Doig CL, Liu S, Sucheston LE, Bianchi A, Khanim FL, Gommersall LM, et al. Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis 2010; 31:1650-60; PMID:20466759; http://dx.doi.org/10.1093/carcin/bgq086
4. Abedin SA, Thorne JL, Battaglia S, Maguire O, Hornung LB, Doherty AP, Mills IG, Campbell MJ. Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis 2009; 30:449-56; PMID:19126649; http://dx.doi.org/10.1093/carcin/bgp005
5. Thorne JL, Campbell MJ. Nuclear receptors and the Warburg effect in cancer. Int J Cancer 2014; [Epub ahead of print]; http://dx.doi.org/10/1002/ijc.29012
6. Campbell MJ, Carlberg C, Koeffler HP. A Role for the PPARgamma in Cancer Therapy. PPAR research 2008; 2008:314974; PMID:18528521; http://dx.doi.org/10.1155/2008/314974
7. Carlberg C, Campbell MJ, Vitamin D Receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 2013; 78:127-36; PMID:23178257; http://dx.doi.org/10.1016/j.steroids.2012.10.019
8. Mongan NP, Gudas LJ. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation; research in biological diversity 2007; 75:853-70; PMID:17634071; http://dx.doi.org/10.1111/j.1432-0436.2007.00206.x
9. Thorne J, Campbell MJ. The vitamin D receptor in cancer. The Proceedings of the Nutrition Society 2008; 67:115-27; PMID:18412986; http://dx.doi.org/10.1017/S0029665108006964
10. Carlberg C, Dunlop TW. An integrated biological approach to nuclear receptor signaling inphysiological control and disease. CritRevEukaryotGene Expr 2006; 16:1-22; http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v16.i1.10
11. Evans RM. The nuclear receptor superfamily: a rosetta stone for physiology. Mol Endocrinol 2005; 19:1429-38; PMID:15914712; http://dx.doi.org/10.1210/ me.2005-0046
12. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1:34-45; PMID:11900250; http://dx.doi.org/10.1038/35094009
13. Metivier R, Penot G, Hubner MR, Reid G, rand H, Kos M, Gannon F. Estrogen receptor-a directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003; 115:751-63; PMID:14675539; http://dx.doi.org/10.1016/S0092-8674(03)00934-6
14. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G, et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008; 452:45-50; PMID:18322525; http://dx.doi.org/10.1038/nature06544
15. Vaisanen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C. Spatio-temporal Activation of Chromatin on the Human CYP24 Gene Promoter in the Presence of 1alpha,25-Dihydroxyvitamin D(3). J Mol Biol 2005; 350:65-77; PMID:15919092
16. Kang Z, Janne OA, Palvimo JJ. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 2004;18:2633-48; PMID:15308689
17. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310:644-8; PMID:16254181; http://dx.doi.org/10.1126/science.1117679
18. Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 2007; 27:380-92; PMID:17679089; http://dx.doi.org/10.1016/j.molcel.2007.05.041
19. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 2000; 60:6111-5; PMID:11085535
20. Khanim FL, Gommersall LM, Wood VH, Smith KL, Montalvo L, O’Neill LP, Xu Y, Peehl DM, Stewart PM, Turner BM, et al. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene 2004; 23:6712-25; PMID:15300237; http://dx.doi.org/10.1038/sj.onc.1207772
21. Rashid SF, Moore JS, Walker E, Driver PM, Engel J, Edwards CE, Brown G, Uskokovic MR, Campbell MJ. Synergistic growth inhibition of prostate cancer cells by 1 a,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene 2001; 20:1860-72; PMID:11313934; http://dx.doi.org/10.1038/sj.onc.1204269
22. Annicotte JS, Iankova I, Miard S, Fritz V, Sarruf D, Abella A, Berthe ML, No€el D, Pillon A, Iborra F, et al. Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer. Mol Cell Biol 2006; 26:7561-74; PMID:17015477; http://dx.doi.org/10.1128/MCB.00605-06
23. Chang TH, Szabo E. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Clin Cancer Res 2002; 8:1206-12.
24. Banwell CM, MacCartney DP, Guy M, Miles AE, Uskokovic MR, Mansi J, Stewart PM, O’Neill LP, Turner BM, Colston KW, et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin Cancer Res 2006; 12:2004-13; PMID:16609009; http://dx.doi.org/10.1158/1078-0432.CCR-05-1218
25. Tavera-Mendoza LE, Quach TD, Dabbas B, Hudon J, Liao X, Palijan A, Gleason JL,White JH. Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. Proc Natl Acad Sci U S A 2008; 105:8250-5; PMID:18550844; http://dx.doi.org/10.1073/pnas.0709279105
26. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. Synergistic activation of functional estrogen receptor (ER)-a by DNA methyltransferase and histone deacetylase inhibition in human ER-a-negative breast cancer cells. Cancer Res 2001; 61:7025-9; PMID:11585728
27. Singh PK, Preus L, Hu Q, Yan L, Long MD, Morrison CD, Nesline M, Johnson CS, Koochekpour S, Kohli M, et al. Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients. Oncotarget 2014; 5:824-40;PMID:24583788
28. Yang X, Bemis L, Su LJ, Gao D, Flaig TW. miR-125b regulation of androgen receptor signaling via modulation of the receptor complex Co-repressor NCOR2. Biores Open Access 2012; 1:55-62; PMID:23514806; http://dx.doi.org/10.1089/biores.2012.9903
29. Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 2009; 69:3356-63; PMID:19351832; http://dx.doi.org/10.1158/0008-5472.CAN-08-4112
30. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R, et al. miR-21: an androgen receptor-regulated microRNA that promotes hormonedependent and hormone-independent prostate cancer growth. Cancer Res 2009; 69:7165-9; PMID:19738047; http://dx.doi.org/10.1158/0008-5472.CAN-09-1448
31. Song G, Wang L. Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma. Nucleic Acids Res 2008; 36:5727-35; PMID:18776219; http://dx.doi.org/10.1093/nar/gkn567
32. Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, Ruskeep€a€a AL, Oresic M, Esau CC, Zdobnov EM, et al. Integration of micro-RNA miR-122 in hepatic circadian gene expression. Genes Dev 2009; 23:1313-26; PMID:19487572; http://dx.doi.org/10.1101/gad.1781009
33. Wang X, Gocek E, Liu CG, Studzinski GP. Micro-RNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle 2009; 8:736-41.
34. Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP. Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Molecular cancer 2011; 10:58; PMID:21592394; http://dx.doi.org/10.1186/1476-4598-10-58
35. Thorne JL, Maguire O, Doig CL, Battaglia S, Fehr L, Sucheston LE, Heinaniemi M, O’Neill LP, McCabe CJ, Turner BM, et al. Epigenetic control of a VDRgoverned feed-forward loop that regulates p21(waf1/ cip1) expression and function in non-malignant prostate cells. Nucleic Acids Res 2011; 39:2045-56; PMID:21088000; http://dx.doi.org/10.1093/nar/gkq875
36. Saramaki A, Banwell CM, Campbell MJ, Carlberg C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 2006; 34:543-54; PMID:16434701; http://dx.doi.org/10.1093/nar/gkj460
37. Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest 1995; 95:973-9; PMID:7883998; http://dx.doi.org/10.1172/JCI117806
38. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10:142-53; PMID:8566748; http://dx.doi.org/10.1101/gad.10.2.142
39. Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, et al. p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol 2008; 4:229; PMID:19034270; http://dx.doi.org/10.1038/msb.2008.65
40. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13:272-86; PMID:18328430; http://dx.doi.org/10.1016/j.ccr.2008.02.013
41. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, et al. The estrogen receptor-a-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A 2009; 106:15732-7; PMID:19706389; http://dx.doi.org/10.1073/pnas.0906947106
42. Martinez NJ, Walhout AJ. The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays 2009; 31:435-45;PMID:19274664; http://dx.doi.org/10.1002/bies.200800212
43. Mangan S, Alon U. Structure and function of the feedforward loop network motif. Proc Natl Acad Sci U S A 2003; 100:11980-5; PMID:14530388; http://dx.doi.org/10.1073/pnas.2133841100
44. Watahiki A, Macfarlane RJ, Gleave ME, Crea F, Wang Y, Helgason CD, Chi KN. Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer. Int J Mol Sci 2013; 14:7757-70; PMID:23574937; http://dx.doi.org/10.3390/ijms14047757
45. Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H. Expression of microRNAs associated with gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate 2013; 73:827-34; PMID:23184537; http://dx.doi.org/10.1002/pros.22626
46. Sun D, Layer R, Mueller AC, Cichewicz MA, Negishi M, Paschal BM, Dutta A. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Oncogene 2014; 33(11):1448-57; PMID:23503464; http://dx.doi.org/10.1038/onc.2013.77
47. Sita-Lumsden A, Dart DA, Waxman J, Bevan CL. Circulating microRNAs as potential new biomarkers for prostate cancer. Br J Cancer 2013; 108:1925-30; PMID:23632485; http://dx.doi.org/10.1038/bjc.2013.192
48. Selth LA, Townley SL, Gillis JL, Tilley WD, Butler LM. Identification of Prostate Cancer-Associated MicroRNAs in Circulation Using a Mouse Mod el of Disease. Methods Mol Biol 2013; 1024:235-46;PMID:23719956; http://dx.doi.org/10.1007/978-1-62703-453-1_19
49. Selth LA, Townley SL, Bert AG, Stricker PD, Sutherland PD, Horvath LG, Goodall GJ, Butler LM, Tilley WD. Circulating microRNAs predict biochemical recurrence in prostate cancer patients. B J Cancer 2013;109:641-50; PMID:23846169; http://dx.doi.org/10.1038/bjc.2013.369
50. Wang L, Tang H, Thayanithy V, Subramanian S, Oberg AL, Cunningham JM, Cerhan JR, Steer CJ, Thibodeau SN. Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Research 2009; 69:9490-7; PMID:19996289; http://dx.doi.org/10.1158/0008-5472.CAN-09-2183
51. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, Senzer N, Eklund AC, Han J, Nemunaitis J. Micro-RNA profile analysis of human prostate cancers. Cancer Gene Ther 2009; 16:206-16; PMID:18949015; http://dx.doi.org/10.1038/cgt.2008.77
52. Siva AC, Nelson LJ, Fleischer CL, Majlessi M, Becker MM, Vessella RL, Reynolds MA. Molecular assays for the detection of microRNAs in prostate cancer. Mol Cancer 2009; 8:17; PMID:19267923; http://dx.doi.org/10.1186/1476-4598-8-17
53. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
54. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68:6162-70; PMID:18676839; http://dx.doi.org/10.1158/0008-5472.CAN-08-0144
55. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer. Ann Surg; 251:499-505; PMID:20134314; http://dx.doi.org/10.1097/SLA.0b013e3181cc939f
56. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006; PMID:18766170; http://dx.doi.org/10.1038/cr.2008.282
57. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112:55-9; PMID:18954897; http://dx.doi.org/10.1016/j.ygyno.2008.08.036
58. Tuoresmaki P, Vaisanen S, Neme A, Heikkinen S, Carlberg C. Patterns of genome-wide VDR locations. PloS one 2014; 9:96105; PMID:24787735; http://dx.doi.org/10.1371/journal.pone.0096105
59. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ, et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33:D284-8; PMID:15608197; http://dx.doi.org/10.1093/nar/gki078
60. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008; 36:D149-53; PMID:18158296; http://dx.doi.org/10.1093/nar/gkm995
61. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. Rna 2008; 14:1012-7; PMID:18426918; http://dx.doi.org/10.1261/rna.965408
62. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular cell 2007; 27:91-105; PMID:17612493; http://dx.doi.org/10.1016/j.molcel.2007.06.017
63. Gamazon ER, Im HK, Duan S, Lussier YA, Cox NJ, Dolan ME, Zhang W. Exprtarget: an integrative approach to predicting human microRNA targets. PloS one 2010; 5:13534; PMID:20975837; http://dx.doi.org/10.1371/journal.pone.0013534
64. Machanick P, Bailey TL. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 2011; 27:1696-7; PMID:21486936; http://dx.doi.org/10.1093/ bioinformatics/btr189
65. Stoppelenburg AJ, von Hegedus JH, Huisin’t Veld R, Bont L, Boes M. Defective control of vitamin D receptor-mediated epithelial STAT1 signalling predisposes to severe respiratory syncytial virus bronchiolitis. J Pathol 2014; 232:57-64; PMID:24105653; http://dx.doi.org/10.1002/path.4267
66. Doig CL, Singh PK, Dhiman VK, Thorne JL, Battaglia S, Sobolewski M, Maguire O, O’Neill LP, Turner BM, McCabe CJ, et al. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Carcinogenesis 2013; 34:248-56; PMID:23087083; http://dx.doi.org/10.1093/carcin/bgs331
67. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20:1352-60; PMID:20736230; http://dx.doi.org/10.1101/gr.107920.110
68. Heikkinen S, Väisänen S, Pehkonen P, Seuter S, Benes V, Carlberg C. Nuclear hormone 1a,25-dihydroxyvitamin D3 elicts a genome-wide shift in the locations of VDR chromatin accupancy. Nucl Acids Res 2011; 39:9181-93; PMID:21846776; http://dx.doi.org/10.1093/nar/gkr654
69. Meyer MB, Goetsch PD, Pike JW. VDR/RXR and TCF4/b-catenin cistromes in colonic cells of colorectal tumor origin: iImpact on c-FOS and c-MYC gene expression. Mol Endocrinol 2012; 26:37-51; PMID:22108803; http://dx.doi.org/10.1210/me.2011-1109
70. Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/. 2013.
71. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:1-25; PMID:16646809.
72. de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004; 20:1453-4; PMID:14871861; http://dx.doi.org/10.1093/bioinformatics/bth078
73. Saldanha AJ. Java Treeview–extensible visualization of microarray data. Bioinformatics 2004; 20:3246-8; PMID:15180930; http://dx.doi.org/10.1093/bioinformatics/bth349
74. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 2009; 25:1991-3; PMID:19435746; http://dx.doi.org/10.1093/bioinformatics/btp299
75. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013; 153:601-13; PMID:23622244; http://dx.doi.org/10.1016/j.cell.2013.03.028
76. Goecks J, Nekrutenko A, Taylor J. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010; 11:R86; PMID:20738864; http://dx.doi.org/10.1186/gb-2010-11-8-r86
77. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, Taylor J. Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol 2010; Chapter 19:Unit 19 0 1-21; PMID:20069535; http://dx.doi.org/10.1002/0471142727
78. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res 2005; 15:1451-5; PMID:16169926; http://dx.doi.org/10.1101/gr.4086505
79. Mooso B, Madhav A, Johnson S, Roy M, Moore ME, Moy C, Loredo GA, Mehta RG, Vaughan AT, Ghosh PM. Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1alpha-Hydroxyvitamin D5 -a calcitriol analog. Genes Cancer 2010; 1:927-40; PMID:21552398; http://dx.doi.org/10.1177/ 1947601910385450